Skip to main content

Advertisement

Table 3 The baseline characteristics of study subjects with three positive components of metabolic syndrome

From: Central obesity is important but not essential component of the metabolic syndrome for predicting diabetes mellitus in a hypertensive family-based cohort. Results from the Stanford Asia-pacific program for hypertension and insulin resistance (SAPPHIRe) Taiwan follow-up study

  With central obesity Without central obesity P
No. of patients 89 44  
Male gender, n (%) 42 (47.2%) 26 (59.1%) 0.163
Age (years) 50.6±9.6 48.4±7.7 0.004
Smoking (packs/day) 5.5±10.3 4.9±9.6 0.616
Body Mass Index (kg/m2) 27.4±2.8 24.8±2.1 <0.001
Waist circumference (cm) 92.3±8.2 81.2±6.2 <0.001
Systolic BP (mmHg) 138±23 136±22 0.500
Diastolic BP (mmHg) 81±14 81±12 0.889
Fasting glucose (mmol/L) 5.0±0.6 5.1±0.6 0.200
2hr pc glucose (mmol/L) 7.3±1.8 7.9±1.4 0.112
Triglyceride (mmol/L) 1.4±0.8 2.1±0.7 <0.001
HDL cholesterol (mmol/L) 1.1±0.2 0.9±0.2 <0.001
Total cholesterol (mmol/L) 4.8±1.0 4.7±1.2 0.772
LDL cholesterol (mmol/L) 3.2±0.9 3.0±1.1 0.564
HOMA-IR 1.9±1.1 1.9±1.0 0.989
Incidence of diabetes (per 1000person-years) 55.3 43.9 0.792
  1. Abbreviations: 2hr pc glucose= post-challenge plasma glucose level at 120 minutes, BP= blood pressure, HDL= high-density lipoprotein, HOMA-IR= homeostasis model assessment for insulin resistance and LDL= low-density lipoprotein.